Explicyte will attend the ASCO Annual Meeting in Chicago this June 2025.
Our CEO, Dr. Alban Bessède, will present two posters highlighting translational studies conducted in collaboration with leading academic and industry partners:
- Spatial transcriptomics reveal crucial determinants of immune exclusion in non-small cell lung cancer From the Precision Medicine BIP Study In collaboration with GSK, Institut Bergonié, and Gustave Roussy
- CCR8⁺ regulatory T cells and their correlation with immunotherapy response in advanced NSCLC In collaboration with Bayer AG, Institut Bergonié, and Gustave Roussy
Alban will be available for 1:1 meetings during the event (June 1–3) to explore opportunities for collaborations in preclinical and translational research in precision oncology.
Book a 1:1 meeting